Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Post by Claridgeon Jun 01, 2019 1:00pm
145 Views
Post# 29791293

Mr. Lade, CEO - Devices division comes from a UHN spin-off

Mr. Lade, CEO - Devices division comes from a UHN spin-offPrior to his nomination as TLT's CEO - Devices division, Kipton Lade was working for a UHN spin-off; Thornhill Medical.


Thornhill Medical has some very interesting innovations by the way.  Take a look:

Thornhill Medical – Innovative Healthcare Devices



Thornhill Medical - Profile


Thornhill Medical, a spin-off company from the University Health Network, develops and manufactures innovative medical products.

Our Vision:

Thornhill Medical – making the inconceivable, possible.

Our Mission:

 

Deliver unique medical devices, using the lung as a portal, to transform current diagnostic and therapeutic patient care.

Our Core Values:

 

Innovation: Pursue the unimaginable through our unique capabilities.

Teamwork: Leverage our collective wisdom through collaboration.

Accountability: Honor commitments to our customers and each other, whatever it takes.

Leadership: Approach challenges with optimism and passion.

People: The well-being and dignity of our employees, customers and patients is at the core of every decision.


Kipton Lade

 

BS, MS, MBA

Director

 

With 25 years of experience in the development and launching of new medical technologies and therapies on a global scale, Mr. Lade is a valued advisor to Thornhill Medical about the introduction and global marketing of the company’s innovative products.


Bullboard Posts